 | Aenco (AEN)ICO Aenco is a “one stop shop” for the delivery of cutting edge institutional financing, prime brokerage, and smart capital solutions for the HealthTech industry, as well as a research and collaboration hub for healthcare companies and projects involved in the field of blockchain development. IMPORTANT: By investing in this business you agree to ourDisclaimer. All information including our rating, is provided merely for informational purposes. CryptoTotem does not provide investment advice. |
Overview
|
OpenWhat is Aenco
Aeneas is commencing application with an EU/EEA based regulator for a full commercial banking license. Aenco, through the said license, will be able to fully integrate its AEN token and solutions in Europe through the commercial bank.
The AEN token will be integrated as major payment currency and transaction support and also a proof of stake basis for account holding, for the conducting of financial services, which shall include:
- Fiat deposit taking;
- Domestic and cross-border fund remittances;
- Foreign exchange transactions;
- Trade services;
- Investment product distribution and asset management.
Additionally, SmartCap Solutions will include alternative financing solutions primarily focused on Receivables financing, Bridge financing and Collateralized lending.
DetailsPre-sales: Jul 27, 2018 - Aug 31, 2018Token supply: 600000000 Soft cap: 15,000,000 USD Hard cap: 60,000,000 USD LegalCountry limitations: China, Hong Kong, Samoa, United StatesRegistration country: Samoa Office address: Vistra Corporate Services Centre, Ground Floor NPF Building, Beach Road, Apia, Samoa | Token infoTicker: AENType: Utility-token Token standard: ERC-223 Token price in USD: 1 Token = 0.100000 USD Accepted currencies: BTC, ETH Bonus program: Pre-ICO Sale (by participation size): >15 ETH: 50% bonus >5 ETH and <15 ETH: 40% bonus >1 ETH and <5 ETH: 30% bonus First 24 hours: additional 5% bpnus ICO Sale: Week 1: 15% bonus Week 2: 10% bonus Week 3: 5% bonus Token distribution: 21% - Company and Team 20% - Reserve and token sale costs 17% - Ecosystem Liquidity 15% - Token Sale 14% - Bonus Allocations 13% - Allocated to Ecosystem Partners / Backers Funds allocation: 40% - Sponsorship and Financial Solutions Platform for HealthTech Partners 30% - Research, Technology Development and Roll Out and Collaboration Research 24% - General Working Capital and Infrastructure Setup Capital Requirement 3% - Marketing & Distribution 3% - Legal & Compliance |
Aenco Roadmap
Aeneas Capital grante Asset Management license by SFC (Hong Kong).
Fund products generate positive returns throughout subprime crisis.
Assets managed by Aeneas deployed into health care private equity and direct investments.
Aeneas Group builds healthtech partnership with Aptorum Group, a multi-disciplinary medical innovations platform based in HK.
Aeneas Capital initiates to expand its licenses with the SFC in HK to include dealing and advising in securities;
Aeneas expands partnerships with healthtech companies specializing in neuro, infectious diseases, and robotic surgery devices.
Aeneas Capital, LLC. established in New Jersey, U.S.A. to set up a FINRA regulated broker dealer (in progress);
Aeneas Group establishing a full-service banking license in Europe (in progress).
June Initiate Private Sale;
Aeneas Capital granted expanded licenses by the SFC in HK to deal and advise in securities;
Community investors outreach.
Expand team: Developers;
1st pipeline healthtech;
ICO launch;
Launch first generation smart wallet & infrastucture (AEN Connect).
Second generation: AENX trading exchange.
Third generation: AENCO prime brokerage platform;
Ongoing service & expansion of pipeline HealthTech partners.
Project team
Advisors
Social media
